Skip to main content
Livermore
Livermore
ZHEN

Creative Planning

SEC CIK
0001540235
Latest filing
Aug 13, 2026

AVXL holding history

Anavex Life Sciences Corp. in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVXL overviewAll 13F holders of AVXLFull Q2 2026 holdings

Shares (Q2 2026)
59,780
Value
$154.8K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of AVXL by Creative Planning, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202659,780$154.8K<0.1%−48,569−44.8%ReducedHolders
Q1 2026108,349$332.6K<0.1%+35,604+48.9%AddedHolders
Q4 202572,745$259.0K<0.1%−4,388−5.7%ReducedHolders
Q3 202577,133$686.5K<0.1%+18,217+30.9%AddedHolders
Q2 202558,916$543.2K<0.1%+8,513+16.9%AddedHolders
Q1 202550,403$432.5K<0.1%+6,453+14.7%AddedHolders
Q4 202443,950$472.0K<0.1%+4,079+10.2%AddedHolders
Q3 202439,871$226.5K<0.1%+14,010+54.2%AddedHolders
Q2 202425,861$109.1K<0.1%+1,730+7.2%AddedHolders
Q1 202424,131$122.8K<0.1%+5,576+30.1%AddedHolders
Q4 202318,555$172.7K<0.1%+6,778+57.6%AddedHolders
Q3 202311,777$77.1K<0.1%−1,159−9.0%ReducedHolders
Q2 202312,936$105.2K<0.1%−178−1.4%ReducedHolders
Q1 202313,114$112.4K<0.1%−688−5.0%ReducedHolders
Q4 202213,802$127.8K<0.1%−6,113−30.7%ReducedHolders
Q3 202219,915$206.0K<0.1%−16,000−44.5%ReducedHolders
Q2 202235,915$360.0K<0.1%+2,700+8.1%AddedHolders
Q1 202233,215$409.0K<0.1%+12,700+61.9%AddedHolders
Q4 202120,515$356.0K<0.1%+20,515NewHolders
Q2 20210$00.0%−17,750−100.0%Sold outHolders
Q1 202117,750$265.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.